Immediate Impact

56 standout
Sub-graph 1 of 24

Citing Papers

Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances
2025 Standout
Advanced disease therapeutics using engineered living drug delivery systems
2025 Standout
2 intermediate papers

Works of Barry A. Schechter being referenced

Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials
2019
Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies
2019
and 1 more

Author Peers

Author Last Decade Papers Cites
Barry A. Schechter 297 232 228 25 537
Ayşen Topalkara 385 213 202 28 634
Panida Kosrirukvongs 301 259 240 29 525
Noriko Inada 169 335 115 47 504
Vannarut Satitpitakul 327 424 289 33 569
Xinhan Cui 384 392 385 19 600
Srihari Narayanan 204 489 272 17 607
Chinn Yi Wong 83 209 113 19 471
Shachar Tauber 290 279 235 23 498
Seth A. Biser 351 380 363 15 557
Rosane Silvestre de Castro 283 304 196 25 459

All Works

Loading papers...

Rankless by CCL
2026